Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations
- 19 April 1999
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 118 (2) , 151-169
- https://doi.org/10.1016/s0009-2797(99)00007-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Structure, Catalytic Mechanism, and Evolution of the Glutathione TransferasesChemical Research in Toxicology, 1997
- Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and InhibitorsDrug Metabolism Reviews, 1997
- Specificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidationLife Sciences, 1995
- Recent Advances: the Cytochrome P450 EnzymesAnnals of Pharmacotherapy, 1995
- Review : Heterogeneity of cytochrome P450 and its toxicological significanceHuman & Experimental Toxicology, 1995
- Biochemistry and molecular biology of drug-metabolizing sulfotransferaseInternational Journal of Biochemistry, 1994
- Human glutathione S-transferasesInternational Journal of Biochemistry, 1994
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Molecular enzymology of human liver cytosolic sulfotransferasesTrends in Pharmacological Sciences, 1991
- Flavin-containing monooxygenases: Catalytic mechanism and substrate specificitiesDrug Metabolism Reviews, 1988